Wells Fargo & Company Pluristem Therapeutics Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$1.18 - $2.18 $5,900 - $10,900	-5,000 Reduced 62.5%	3,000 $4,000
Q1 2022 May 16, 2022	BUY	$1.42 - $2.14 $1,418 - $2,137	999 Added 14.27%	8,000 $17,000
Q4 2021 Feb 14, 2022	BUY	$1.46 - $3.1 $1,460 - $3,100	1,000 Added 16.66%	7,001 $10,000
Q3 2021 Nov 15, 2021	SELL	$2.65 - $3.96 $2,647 - $3,956	-999 Reduced 14.27%	6,001 $16,000
Q2 2021 Aug 16, 2021	BUY	$3.54 - $4.95 $3,486 - $4,875	985 Added 16.38%	7,000 $28,000
Q1 2021 May 13, 2021	SELL	$4.48 - $8.49 $16,992 - $32,202	-3,793 Reduced 38.67%	6,015 $29,000
Q4 2020 Feb 09, 2021	BUY	$5.93 - $11.46 $46,289 - $89,456	7,806 Added 389.91%	9,808 $69,000
Q3 2020 Nov 05, 2020	BUY	$8.4 - $11.48 $4,200 - $5,740	500 Added 33.29%	2,002 $21,000
Q2 2020 Aug 13, 2020	BUY	$3.25 - $12.43 $3,906 - $14,940	1,202 Added 400.67%	1,502 $13,000
Q1 2020 May 14, 2020	BUY	$2.89 - $4.66 $867 - $1,398	300 New	300 $1,000

About PLURISTEM THERAPEUTICS INC

Ticker PSTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,347,600
Market Cap $32.3M

More about PSTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.